Global endometrial ablation devices market to grow at CAGR of 4.95%

The global endometrial ablation devices market was valued at USD 3,538.60 million in 2022 and growing at a CAGR of 4.95% during the forecast period (2023 to 2028); it is expected to reach USD 4,719.50 million by 2028. The global endometrial ablation devices market is growing owing to the increasing prevalence of abnormal vaginal bleeding, polycystic ovarian disease (PCOD), menorrhagia, and other gynecological disorders. Moreover, the innovations in product development and the growth in the surging product launches and approvals are also providing momentum to the market growth. Some of the leading players in the Endometrial Ablation Devices Market include Medtronic, Johnson & Johnson Services, Inc., Olympus, Minerva Surgical, Inc., Hologic, Inc., CooperSurgical Inc., Richard Wolf GmbH, AngioDynamics, KARL STORZ SE & Co. KG, IDOMAN-MED, Arthrex, Inc., Channel Medsystems, Inc., Gynesonics, Boston Scientific Corporation, AEGEA Medical, and others.

DelveInsight’s “Endometrial ablation devices market insight, competitive landscape and market forecast 2028” research report provides the current and forecasted endometrial ablation devices market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.

Endometrial ablation devices market: Overview
Endometrial ablation devices are surgical devices that are used to remove a thin layer of tissue (endometrium) that lines the uterus. The devices are used for the treatment of heavy menstrual bleeding, endometrial cancer, gynecological disorders, and others.

To provide a better understanding of the market dynamics, DelveInsight’s “Endometrial ablation devices market” report provides an in-depth assessment of the market by product type (cryoablation devices, hydrothermal ablators, thermal balloon ablator, radiofrequency ablators, microwave ablators, and others), end-user (hospitals & clinics, specialty clinics, and others), and geography (north america, europe, asia-pacific, and rest of the world). As per the assessment by DelveInsight, in the product type segment of the endometrial ablation devices market, the radiofrequency ablators category is expected to amass a significant revenue share in the upcoming years owing to the several advantages offered by the category. The radiofrequency ablators offer speedy treatment and recovery, higher efficacy as compared to other options, more effective for the treatment of small cancers, and offer a minimally invasive approach.

Endometrial ablation devices market analysis
The demand for the endometrial ablation devices is growing at an exponential rate globally. The increase in the prevalence of gynecological disorders such as menorrhagia, Polycystic Ovarian Disease (PCOD), and others, is one of the key factors for the rising demand for the endometrial ablation devices. Endometrial ablation devices play a key role in effective treatment for menorrhagia PCOD, which is expected to stimulate the overall market growth during the forecast period.

The increasing patient preference for minimally invasive surgeries is also likely to drive the market growth. Endometrial ablation offers advantages over conventional surgeries, such as short procedure time, faster recovery, high efficiency, and lower post-treatment pain. Thus, such advantages may increase the adoption of minimally invasive treatment over the other treatment options. Furthermore, several major MedTech companies are working to develop new and innovative Endometrial Ablation Devices. The increasing developments made by the key players in the ablation segment are also contributing to the market’s growth. Overall, the above-mentioned factors are contributing to the growth of the endometrial ablation devices market during the forecast period from 2023-2028.

However, some of the key risk factors associated with endometrial ablation procedures such as infection, tearing of uterine wall, hemorrhage, and others are expected to hamper the endometrial ablation devices market growth.

Endometrial ablation devices – Global market assessment and forecast
As per DelveInsight, among all the regions, North America is anticipated to hold the largest share of the endometrial ablation devices market in the upcoming years. The growing prevalence of gynecological disorders such as PCOS, rising incidences of abnormal uterine bleeding (AUB), menorrhagia, and escalating cases of cancer such as uterine cancer among women is one of the key factors driving the North American endometrial ablation devices market growth. As per the estimate, Menorrhagia affected more than 10 million American women each year, indicating one out of every five women having it. Moreover, about 66,000+ new cases of uterus cancer are expected to be diagnosed in the United States in 2023. Similarly, other countries in the region are also expected to exhibit a comparable growing trend for the new cases of uterus cancer.

Coupled with the factors mentioned above, the strong presence of MedTech companies in the region, and increasing strategic planning among the key players are also expected to drive the market of endometrial ablation devices.

Endometrial ablation devices market – Key developments and breakthroughs
Over the years, the endometrial ablation devices market has evolved significantly, owing to the active participation of global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered in the domain.

Some of the major advancements in the Endometrial Ablation Devices market in recent years include 

• In February 2023, Hologic announced the approval of NovaSure V5 global endometrial ablation device (GEA) in Canada and Europe, which is a minimally invasive device that emits precisely measure radio-frequency energy to safely remove the endometrium, to treat Abnormal Uterine Bleeding (AUB).
• In December 2022, RF Medical received US FDA approval for its MYGEN M-3004 generator and MYOBLATE radiofrequency ablation system. MYGEN M-3004 enables a combination of monopolar and bipolar modes to deliver radiofrequency energy, while MYOBLATE electrodes are intended for coagulation and ablation of soft tissue to treat fibroids in a minimally invasive manner.
• In October 2022, Channel Medsystems, Inc., launched Cerene Cryotherapy Device for the treatment of heavy menstrual bleeding (HMB). It provides a minimally invasive endometrial ablation treatment using cooling technology (Cryoablation) that reduces menstrual bleeding and dysmenorrhea, while naturally minimizing pain without requiring general anesthesia.
• In October 2021, Hologic announced the acquisition of Bolder Surgical, for USD 160 million. The complementary acquisition of Bolder Surgical added to Hologic’s surgical product line, which included the NovaSure® endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure® tissue removal devices for the treatment of intrauterine fibroids and polyps, the Acessa® laparoscopic radiofrequency ablation system for the treatment of fibroids, among others.
• In February 2021, CooperSurgical announced the acquisition of AEGEA Medical and its FDA-approved Mara Water Vapor Ablation system.

Key companies in the endometrial ablation devices market
Globally, some of the leading MedTech giants working in the Endometrial Ablation Devices market include Medtronic, Johnson & Johnson Services, Inc., Olympus, Minerva Surgical, Inc., Hologic, Inc., CooperSurgical Inc., Richard Wolf GmbH, AngioDynamics, KARL STORZ SE & Co. KG, IDOMAN-MED, Arthrex, Inc., Channel Medsystems, Inc., Gynesonics, Boston Scientific Corporation, AEGEA Medical, and others. Owing to the rising demand and favorable growth opportunities for revenue generation, several new players are anticipated to enter the market, thereby leading to high competitiveness in the domain.

Scope of the endometrial ablation devices market report:

• Study period – 2020-2028
• Geography covered – North America, Europe, Asia-Pacific, and Rest of the World

• Endometrial ablation devices market assessment –
  • By product type – Cryoablation devices, Hydrothermal Ablators, Thermal Balloon Ablator, Radiofrequency Ablators, Microwave Ablators, and Others
  • End-user – Hospitals & Clinics, Specialty Clinics, and Others
• Porter’s five forces analysis, product profiles, case studies, KOL’s views, analyst’s views

DelveInsight